Dr. Erin Bassett joined BioCanRx in 2024 as Director of Regulatory Affairs and Policy. Erin has scientific research and policy experience in academic, industry, and not-for-profit environments. She is passionate about translational research, evidence-based policy, and the benefits of collaboration across sectors to realize the full potential of Canadian-led therapeutic development. Prior to joining BioCanRx, Erin was an R&D Program Director at Tetra Bio-Pharma, where she led a range of activities including nonclinical safety studies, drug formulation and manufacturing development, and preparation of clinical trial application packages for Health Canada and the FDA. Before her time in industry, Erin was a Research Associate at the Council of Canadian Academies, a not-for-profit organization that assesses scientific evidence to inform public policy. She also worked as a Research Associate at the Ottawa Hospital Research Institute (OHRI), where she investigated the mechanisms behind pediatric brain tumor initiation. Erin holds a PhD in developmental neuroscience from McMaster University, received in 2010.